Cancer of the fallopian tube
In Oncology Practicecancer of the uterine tubeis considered a rather rare pathology and occurs in approximately 1% of patients with malignant neoplasms of female genital organs. The disease is mainly diagnosed in women over 50 years of age. Tumor, as a rule, proceeds unilaterally.
Causes of tubal cancer
The exact cause of tumor formation in this area has not been established to date. Gynecologists point to the following risk factors:
- frequent inflammation of the uterine appendages;
- senior age and absence of anamnesis in the anamnesis;
- violation of the periodicity of the menstrual cycle.
Recent scientific studies indicate an important role of the virus factor, in particular, the second type herpes virus and the papilloma virus.
Symptoms and early signs
The first and key sign of this oncology is the allocation, which can be serous-purulent or bloody. The amount of fluid released can vary from a few drops to profuse bleeding. In most cases, from the time of detection of the first symptoms to the establishment of the final diagnosis, passes from 6 months to 1 year.
The second manifestation of the tumor is pain, which is localized on the side of the lesion. As the malignancy grows, the pain syndrome gradually builds up and spreads to the lower third of the abdomen.
Oncoforming of the fallopian tube can be palpated as a small seal with a diameter of about 3 cm. It should be borne in mind that in some clinical cases the initial phases of the disease can be asymptomatic.
Especially onkostorozhennost doctors should cause patients older than 40 years, who have increased uterine appendages without obvious signs of inflammation in them. Also, a detailed survey requires women, in the analysis of which a reduced concentration of leukocytes, increased ESR and normal body temperature.
Preliminary diagnosis is determined on the basis of the following studies:
- Gynecological examination and palpation of female genital organs.
- Ultrasound examination, which allows for a qualitative diagnosis in patients with different constitutions.
- Contrast radiography of pelvic organs.
- Cytological analysis of uterine secretions.
Patients should take into account that the above methods are related to express diagnostics. In most cases, the final diagnosis is determined after a laboratory analysis of the biological material removed during the surgical operation.
In modern gynecology, the most promising area for early diagnosis of oncology of the uterus and its appendages is an analysis of the oncomarker of the uterus and ovarian cancer markers.
Modern treatment of uterine tube cancer
The treatment of uterine tube cancer is exclusively surgical. Medication and radiation exposure to the mutation focus is carried out as an additional technique for radical intervention.
Modern chemotherapy consists in taking platinum-containing cytostatic agents. The effectiveness of such treatment can be assessed only one year after the start of the drug course.
Radiation therapy can affect both the pelvic organs and the entire abdominal cavity. Many practicing oncologists recommend immediately irradiating the entire peritoneum, which is associated with a high risk of vetasal metastases and relapses of the disease.
Radical intervention includes complete excision of the uterus, appendages, epiploon, regional lymph nodes. The operation is performed under general anesthesia. The remote material is sent to histological analysis without fail.
In the late phase of malignant growth, the surgeon partially removes the tumor. But even this incomplete excision can significantly prolong the duration of life of the cancer patient.
Is pregnancy possible with a fallopian tube cancer?
After radical treatment of the tumor process, unfortunately, pregnancy is impossible. Some scientists conceive a child as a means of preventing the development of gynecological neoplasms.
This pathology has an unfavorable course. Even early diagnosis of cancer and adequate treatment can not guarantee the patient's recovery. For example,cancer of the uterine tubeat the third stage provides for a 28% five-year survival rate. Such a prognosis is explained by the early formation of metastases and the asymptomatic course of the tumor in the initial stage..